Blackstone Life Sciences Fund VI blows past fundraise target

The platform boasts a regulatory approval rate of nearly twice the industry average, division head Nicholas Galakatos tells Buyouts.

1 April 2026•3 mins read
LinkedInXEmail
LinkedInXEmail

Related articles